Reinvigorating therapeutic cancer vaccines

Lessons learned from the rapid deployment of vaccines during the COVID-19 pandemic are reinvigorating the cancer vaccine field. Using delivery platforms including mRNA and synthetic long peptides, recent clinical trials have demonstrated that cancer vaccines are safe, feasible, and can be associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Robles-Oteiza, Camila, Wu, Catherine J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612210/
https://www.ncbi.nlm.nih.gov/pubmed/35429774
http://dx.doi.org/10.1016/j.coi.2022.102176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612210/
https://www.ncbi.nlm.nih.gov/pubmed/35429774
http://dx.doi.org/10.1016/j.coi.2022.102176

Ejemplares similares